At the 16th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies in Las Vegas, Zannos Grekos, MD, director of Cardiac and Vascular Disease for Regenocyte Therapeutic (www.regenocyte.com), addressed physicians from around the world with a presentation on patients treated with pre-engineered Adult Stem Cells. In the presentation, Grekos showed the successful engraftment of stem cells into damaged organs and subsequent regeneration of tissue. The clinical success has spurred a project entailing growing organs for transplant from patients’ own stem cells using technology developed by National Aeronautic Space Association (NASA). In describing details of the stem cells project Grekos stated, “This is the logical next step in harnessing the regenerative power of stem cells. This will be the next phase in turning science into medicine.”
LAS VEGAS, Nev. (Business Wire EON) December 22, 2008 -- The presentation also cited stem cells treatment results at one month through one year follow up. The Regenocyte team of international scientists and physicians have been treating cardiac, vascular, pulmonary, and kidney diseases, with plans next year to accept patients suffering from macular degeneration and neurological diseases.
Athina Kyritsis, MD, chair of Regenocyte's Medical Advisory Committee, explains "the findings presented today are based on several years of Regenocyte's clinical experience using Autologous Adult Stem Cell Therapy. I believe we have only begun to discover what Adult Stem Cells can accomplish in altering the course of diseases currently believed to be untreatable with not only improved clinical results, but also a financial savings to society."
Hector Rosario, MD, chief of Interventional Cardiology for the Dominican Republic division of Regenocyte, is thrilled with the clinical outcomes to date. "It is personally very gratifying to alter the prognosis in patients who have exhausted all other options," Rosario says. Leonel Francisco Liriano, MD, professor of medicine at Pontifical Catholic University School of Medicine and medical director of the Regenocyte Dominican Republic division added that "patient safety is always paramount. We're achieving these results with a treatment that poses minimal risk, much lower than traditional surgical procedures."
Regenocyte Therapeutic is currently using Adult Stem Cells Therapy to treat Congestive Heart Failure, Cardiomyopathy, Peripheral Artery Disease, Coronary Artery Disease, Kidney Disease, Ischemic Heart Disease, Pulmonary diseases (COPD, Pulmonary Fibrosis, and Pulmonary Hypertension) and Early Senile Dementia. Patients can call 866-216-5710 or visit www.regenocyte.com for information or consultation.
Read the full story at http://www.prweb.com/releases/adult_stem/stem_cells/prweb1786234.htm
Copyright©2008 Vocus, Inc.
All rights reserved